University of Nebraska Medical Center

Medicine & Life Sciences

1. Neoplasms 100%
2. Therapeutics 84%
3. Child 73%
4. Proteins 62%
5. Genes 50%
6. HIV-1 49%
7. Pancreatic Neoplasms 48%
8. HIV 47%
9. Pediatrics 46%
10. Liver 44%
11. Transplants 39%
12. Rheumatoid Arthritis 39%
13. Infections 38%
14. Survival 38%
15. Brain 37%
16. Growth 37%
17. DNA 36%
18. Health 36%
19. Wounds and Injuries 36%
20. Guidelines 36%
21. Chronic Obstructive Pulmonary Disease 35%
22. Heart Failure 35%
23. Pharmaceutical Preparations 34%
24. Lung 33%
25. Population 33%
26. Kidney 33%
27. Breast Neoplasms 31%
28. Ethanol 31%
29. Exercise 31%
30. Macrophages 30%
31. Mortality 30%
32. Education 30%
33. In Vitro Techniques 30%
34. Epithelial Cells 30%
35. Alcohols 30%
36. Mutation 30%
37. Peptides 29%
38. Non-Hodgkin's Lymphoma 29%
39. Students 28%
40. Lymphoma 28%
41. Drug Therapy 28%
42. Safety 27%
43. Neoplasm Metastasis 26%
44. T-Lymphocytes 26%
45. Inflammation 26%
46. Butyrylcholinesterase 25%
47. Enzymes 24%
48. Stem Cells 24%
49. Adenocarcinoma 24%
50. Liver Transplantation 23%
51. Cell Line 23%
52. Animals 23%
53. Gene Expression 23%
54. Phenotype 23%
55. Biomarkers 23%
56. Practice Guidelines 23%
57. Transplantation 22%
58. Apoptosis 22%
59. Prostatic Neoplasms 22%
60. Mucins 21%
61. Physicians 21%
62. Delivery of Health Care 21%
63. Incidence 21%
64. Cytokines 21%
65. Virus Diseases 21%
66. MicroRNAs 21%
67. Eye 21%
68. Serum 20%
69. Databases 20%
70. Costs and Cost Analysis 20%
71. Lymphoma, Large B-Cell, Diffuse 20%
72. Pandemics 20%
73. Technology 20%
74. Viruses 20%
75. Systematic Reviews 20%
76. Antibodies 20%
77. Genome 20%
78. Cattle 20%
79. Diet 19%
80. Nicotine 19%
81. Confidence Intervals 19%
82. Fibroblasts 19%
83. Equipment and Supplies 19%
84. Carcinogenesis 19%
85. Coronavirus 19%
86. Clinical Trials 19%
87. Recurrence 18%
88. Radiotherapy 18%
89. Bone and Bones 18%
90. Bone Marrow 18%
91. Depression 18%
92. Pharmacokinetics 18%
93. Phosphorylation 18%
94. Transforming Growth Factors 18%
95. Randomized Controlled Trials 18%
96. Mothers 17%
97. Messenger RNA 17%
98. Transplant Recipients 17%
99. Anti-Bacterial Agents 17%
100. Ligands 17%